Trans American Aquaculture (GRPS) Cash from Investing Activities (2023 - 2025)
Trans American Aquaculture (GRPS) reported Cash from Investing Activities of $10616.0 for Q3 2025, down 46.14% on a YoY basis from $19710.0 in Q3 2024, and little changed quarter-over-quarter from $10616.0 in Q2 2025.
Trans American Aquaculture (GRPS) Cash from Investing Activities (2023 - 2025) Analysis & Trends
Trans American Aquaculture has reported Cash from Investing Activities for 3 years, with the latest figure at $10616.0 in Q3 2025.
- For the quarter ending Q3 2025, Cash from Investing Activities fell 46.14% year-over-year to $10616.0; the trailing twelve-month figure through Sep 2025 stood at $6.7 million (up 89718.92% YoY), and the FY2024 full-year result was $6.7 million, up 44491.3% from the prior year.
- Cash from Investing Activities for Q3 2025 stood at $10616.0, roughly flat from $10616.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was $6.7 million in Q4 2024, with the low at -$15132.0 in Q1 2023.
- Historically, Cash from Investing Activities has averaged $1.1 million across 3 years, with a median of $10616.0 in 2025.
- Annual changes were most pronounced in 2024 — Cash from Investing Activities increased 19.27% — and 2025, when it sank 46.14%.
- Trans American Aquaculture's Cash from Investing Activities stood at -$15132.0 in 2023, then soared by 44441.78% to $6.7 million in 2024, then plunged by 99.84% to $10616.0 in 2025.
- The last three Cash from Investing Activities figures came in at $10616.0 (Q3 2025), $10616.0 (Q2 2025), and $6.7 million (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 229.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | -87.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 743.70 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | -506.20 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -60.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -2.08 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -15.45 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 25.99 Mn |
| 10 | Trans American Aquaculture | - | - | - | 10,616.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 10,616.00 |
| Sep 30, 2025 | 10,616.00 |
| Jun 30, 2025 | 10,616.00 |
| Jun 30, 2025 | 10,616.00 |
| Dec 31, 2024 | 6.71 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | 19,710.00 |
| Sep 30, 2024 | 19,710.00 |
| Mar 31, 2024 | -12,216.00 |
| Mar 31, 2024 | -12,216.00 |
| Mar 31, 2023 | -15,132.00 |
| Mar 31, 2023 | -15,132.00 |